Amyloid Beta-peptide 1-40 and Alzheimer's Disease

NACompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 14, 2018

Study Completion Date

March 14, 2018

Conditions

Alzheimer Disease

Interventions

BIOLOGICAL

spinal fluid collection

Trial Locations (1)

Chu de Reims, Reims

All Listed Sponsors

lead

CHU de Reims

OTHER

NCT02770482 - Amyloid Beta-peptide 1-40 and Alzheimer's Disease | Biotech Hunter | Biotech Hunter